To increase funding for cancer research by the National Cancer Institute to be more in proportion to the mortality rates of cancer.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill expands a neutral technical change provision: 2. Findings Congress finds the following: Cancer is one of the leading causes of death in the world and has touched nearly every life, either directly or indirectly. Cancer, expands a appropriation, compliance mandate provision: 3. Increasing NCI budget for cancer research To conduct or support cancer research, there is hereby appropriated, for each of fiscal years 2026 through 2030, to, and expands a appropriation, reporting req, compliance mandate provision: 4. Report to Congress on cancer drug shortages. It relies on appropriations, compliance mandates, and reporting requirements. The main policy areas are Finance and Healthcare.
Who Benefits and How
The available clause analysis does not identify a specific beneficiary group.
Who Bears the Burden and How
No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.
Key Provisions
- Expands a neutral technical change provision: 2. Findings Congress finds the following: Cancer is one of the leading causes of death in the world and has touched nearly every life, either directly or indirectly. Cancer...
- Expands a appropriation, compliance mandate provision: 3. Increasing NCI budget for cancer research To conduct or support cancer research, there is hereby appropriated, for each of fiscal years 2026 through 2030, to...
- Expands a appropriation, reporting req, compliance mandate provision: 4. Report to Congress on cancer drug shortages.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.
At a Glance
What This Bill Does
The bill expands a neutral technical change provision: 2. Findings Congress finds the following: Cancer is one of the leading causes of death in the world and has touched nearly every life, either directly or indirectly. Cancer, expands a appropriation, compliance mandate provision: 3. Increasing NCI budget for cancer research To conduct or support cancer research, there is hereby appropriated, for each of fiscal years 2026 through 2030, to, and expands a appropriation, reporting req, compliance mandate provision: 4. Report to Congress on cancer drug shortages.
Key Policy Areas
Finance, Healthcare
Primary Purpose
The bill expands a neutral technical change provision: 2. Findings Congress finds the following: Cancer is one of the leading causes of death in the world and has touched nearly every life, either directly or indirectly. Cancer, expands a appropriation, compliance mandate provision: 3. Increasing NCI budget for cancer research To conduct or support cancer research, there is hereby appropriated, for each of fiscal years 2026 through 2030, to, and expands a appropriation, reporting req, compliance mandate provision: 4. Report to Congress on cancer drug shortages.
Policy Domains
Sponsors
Legislative Progress
IntroducedMr. Fitzpatrick (for himself and Mrs. Dingell) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology